Log In
BCIQ
Print this Print this
 

Tobrate, oral tobramycin

  Manage Alerts
Collapse Summary General Information
Company Enteris BioPharma Inc.
DescriptionOral tablet formulation of the aminoglycoside antibiotic tobramycin that uses Peptelligence technology
Molecular Target
Mechanism of ActionBactericidal agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationUrinary tract infection (UTI)
Indication DetailsTreat uncomplicated urinary tract infection (UTI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today